Kodiak Sciences Inc. KOD 深 滬
等待開盤 05-13 09:30:00 美东时间
39.49
-0.360
-0.90%
華盛通- 最 高39.72
- 今 開39.72
- 成交量 40.73万股
- 最 低 37.46
- 昨 收 39.85
- 總市值 24.55亿
- 52周最高 47.8417
- 市盈率 靜 --
- 換手率 0.66%
- 52周最低 3.26
- 委 比 -48.44%
- 總股本 6215.57万
- 歷史最高 171.21
- 量 比 0.55
- 振 幅 5.67%
- 歷史最低 1.37
- 每 手 1
- 風險率 12.19%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Chardan Capital Upgrades Kodiak Sciences to Buy, Raises Price Target to $61
Chardan Capital analyst Daniil Gataulin upgrades Kodiak Sciences (NASDAQ:KOD) from Neutral to Buy and raises the price target from $14 to $61.
05-11 20:11
Kodiak Sciences' KSI-101 MESI Data From Tertiary Care Uveitis Practice Consistent With Phase 1b APEX Study Results
Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care uveitis practice demonstrate outcomes consistent with results from the U.S. Phase 1b APEX study, supporting continued
05-01 14:35
Kodiak says Asian MESI cohort data support Phase 3 expansion of KSI-101 program
Kodiak says Asian MESI cohort data support Phase 3 expansion of KSI-101 program Kodiak Sciences scheduled new clinical updates on KSI-101 for macular edema secondary to inflammation at American Uveitis Society on May 2, 2026, with additional data slated for ARVO May 3-7, 2026. Results from tertiary-
05-01 12:24
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers
The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 13-day rally.
04-18 04:59
Kodiak Sciences CFO John A. Borgeson disposes of common shares worth 1.2 million
Kodiak Sciences CFO John A. Borgeson disposes of common shares worth 1.2 million Kodiak Sciences CFO John A. Borgeson exercised stock options for 30,000 shares at USD 1.04 on April 2, 2026. He sold 30,000 shares on April 2, 2026, at weighted-average prices ranging from USD 39.14 to USD 41.77. Direct
04-03 08:27
U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics
U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics April 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Doordash, Phillips 66 and United Therapeutics, on Thursday. HIGHLIGHTS * Doordash DASH.O : JP Morga
04-02 15:21
PVH, Micron, Intel And Other Big Stocks Moving Higher On Wednesday
U.S. stocks rise, Dow Jones up 400+ points. PVH Corp beats expectations, shares jump 9.9%. Other big gainers include RGC, TH, PLAY, SHAZ, HTT, MFI, RZLV, FSLY, WDC, KOD, LITE, SanDisk.
04-01 23:48
Kodiak Sciences GAAP EPS of -$1.04 in-line
Kodiak Sciences press release (KOD): Q4 GAAP EPS of -$1.04 in-line. Kodiak ended 2025 with $209.9 million of cash and cash equivalents. The firm believes that its current cash and cash equivalents wil...
04-01 04:49
Kodiak Sciences Q4 EPS $(1.04) Misses $(1.00) Estimate
Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(1.00) by 4.1 percent. This is a 23.81 percent decrease over losses of $(0.84) per share from
04-01 04:47
